Skip to main content
UTHR
NASDAQ Life Sciences

Officer Paul Mahon Files Intent to Sell $4M in Shares, Continuing Recent Distribution Trend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$478.93
Mkt Cap
$20.621B
52W Low
$266.98
52W High
$519.99
52W Position info
79% above low
Off High info
7.9% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

UTHR sits 79% above its 52-week low of $266.98.

Summary

Officer Paul Mahon filed a Form 144 to sell 8,300 shares worth approximately $4.01 million, extending a trend of significant share dispositions totaling over $33 million in the last three months.


Key Events · Ownership and Investor Activity · UTHR

  • Officer Files Intent to Sell

    Officer Paul Mahon has filed a Form 144 indicating an intent to sell 8,300 shares of common stock.

  • Proposed Sale Value

    The approximate market value of the shares intended for sale is $4,010,939.31.

  • Continuation of Recent Sales

    This proposed sale follows a pattern of dispositions by the same officer, who has sold a total of 60,600 shares with gross proceeds of $29,364,503.43 in the past three months, bringing total sales (proposed + recent) to over $33 million.

  • Nature of Acquisition

    The shares to be sold were acquired through a stock option exercise.


Analysis · UTHR · Life Sciences

This Form 144 indicates that Officer Paul Mahon intends to sell an additional 8,300 shares, valued at approximately $4.01 million. This proposed sale is part of a larger pattern, as Mahon has sold over $33 million worth of shares in the past three months. While the current proposed sale is a modest percentage of the company's market capitalization, the consistent and significant volume of sales by a key officer suggests a continued reduction in personal holdings, often associated with liquidity or diversification rather than a direct negative signal about the company's fundamentals. Investors should note the ongoing distribution by this insider.

At the time of this filing, UTHR was trading at $478.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.6B. The 52-week trading range was $266.98 to $519.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UTHR - Latest Insights

UTHR
Jul 23, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $527.07
Real-time Price: $528.47 info
Change: +$1.40 (+0.27%) info
Market Cap: $22.432B info
UTHR
Jul 06, 2026, 7:19 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $553.93
Real-time Price: $528.47 info
Change: -$25.46 (-5%) info
Market Cap: $22.432B info
UTHR
Jul 02, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $541.83
Real-time Price: $528.47 info
Change: -$13.36 (-2%) info
Market Cap: $22.432B info
UTHR
Jul 01, 2026, 4:52 PM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $547.15
Real-time Price: $528.47 info
Change: -$18.68 (-3%) info
Market Cap: $22.432B info
UTHR
Jun 29, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $544.92
Real-time Price: $528.47 info
Change: -$16.45 (-3%) info
Market Cap: $22.432B info